BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6790559)

  • 1. Secondary hyperparathyroidism in idiopathic renal hypercalciuria: fact or theory?
    Burckhardt P; Jaeger P
    J Clin Endocrinol Metab; 1981 Sep; 53(3):550-5. PubMed ID: 6790559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction.
    Evans RA; Hills E; Wong SY; Wyndham LE; Eade Y; Dunstan CR
    Q J Med; 1984; 53(209):41-53. PubMed ID: 6324269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of secondary hyperparathyroidism in most patients with renal hypercalciuria.
    Olmer M; Berland Y; Argemi B
    Kidney Int Suppl; 1983 Dec; 16():S175-9. PubMed ID: 6330424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize distinctive hypercalciuric subgroups.
    Broadus AE; Dominguez M; Bartter FC
    J Clin Endocrinol Metab; 1978 Oct; 47(4):751-60. PubMed ID: 233682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria.
    Coe FL; Canterbury JM; Firpo JJ; Reiss E
    J Clin Invest; 1973 Jan; 52(1):134-42. PubMed ID: 4682379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ionized calcium and parathyroid hormone in renal stone disease.
    Muldowney FP; Freaney R; McMullin JP; Towers RP; Spillane A; O'Connor P; O'Donohoe P; Moloney M
    Q J Med; 1976 Jan; 45(177):75-86. PubMed ID: 1257401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary hyperparathyroidism: clinical and laboratory spectrum].
    Heilberg IP; Ramos OL; Schor N
    Rev Paul Med; 1989; 107(4-6):212-8. PubMed ID: 2640506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid hormone sensitivity in primary hyperparathyroidism and idiopathic hypercalciuria: effects on postadenylate cyclase parameters.
    McElduff A; Lissner D; Wilkinson M; Posen S
    J Clin Endocrinol Metab; 1990 May; 70(5):1457-61. PubMed ID: 2159486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism.
    Ramirez JA; Goodman WG; Gornbein J; Menezes C; Moulton L; Segre GV; Salusky IB
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1489-94. PubMed ID: 8501155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism.
    Ljunghall S; Larsson K; Lindh E; Lindqvist U; Rastad J; Akerström G; Wide L
    Surgery; 1991 Jul; 110(1):47-53. PubMed ID: 1907770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximal PTH secretory rate and set point for calcium in normal subjects and patients with primary hyperparathyroidism. In vivo studies.
    Gardin JP; Patron P; Fouqueray B; Prigent A; Paillard M
    Miner Electrolyte Metab; 1988; 14(4):221-8. PubMed ID: 2850460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation and treatment of renal calculi associated with hypercalciuria.
    Holdaway IM; Evans MC; Frengley PA; Ibbertson HK
    J Endocrinol Invest; 1982; 5(6):361-5. PubMed ID: 6302159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of renal calculi in distal renal tubular acidosis. Possible role of parathyroid hormone.
    Lee DB; Drinkard JP; Gonick HC; Coulson WF; Cracchiolo A
    Clin Orthop Relat Res; 1976; (121):234-42. PubMed ID: 991509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal lithiasis in idiopathic hypercalciuria and primary hyperparathyroidism].
    Burckhardt P
    Ann Med Interne (Paris); 1986; 137(3):216-9. PubMed ID: 3767188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bone involvement in idiopathic calcium lithiasis].
    Ghazali A; Bataille P; Solal MC; Marié A; Brazier M; Sebert JL; Prin L; Fournier A
    Nephrologie; 1995; 16(5):351-69. PubMed ID: 7566325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal resistance to endogenous parathyroid hormone in pateints with early renal failure. A possible cause for secondary hyperparathyroidism.
    Llach F; Massry SG; Singer FR; Kurokawa K; Kaye JH; Coburn JW
    J Clin Endocrinol Metab; 1975 Aug; 41(2):339-45. PubMed ID: 169280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of adenosine 3',5'-monophosphate excretion and an oral calcium tolerance test in the diagnosis of mild primary hyperparathyroidism.
    Madvig P; Young G; Marcus R
    J Clin Endocrinol Metab; 1984 Mar; 58(3):480-7. PubMed ID: 6319454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.